February 6, 2025 - Dexin Group (BVI) Ltd, a global leading manufacturing and trading enterprise, officially announced today that the company has submitted an initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC). It plans to be listed on the NASDAQ Capital Market on May 1, 2025, with the stock code DEXN and tracking code DC1179ON. The total funds expected to be raised in this IPO are approximately $80 million, which will be used to deepen the core business layout, accelerate technological innovation, and expand the global market.
Company Overview and Business Advantages
Dexin Group (the main registered code entity: Dexin Group (BVI) Ltd) is headquartered in Manhattan, the United States. Its operating entity is Guangzhou Dexin Enterprise Development Co., Ltd. It is a comprehensive enterprise integrating production, manufacturing, sales, and trade. Relying on its advanced manufacturing capabilities and efficient supply chain system, the company's business covers the fields of industrial equipment, consumer products, and cross - border trade. It is committed to providing high - quality solutions to global customers.
The company's operating entity is located in Guangzhou, and it has established branches in regions such as Asia, North America, and Europe, forming a global operation network. In recent years, Dexin Group has achieved a stable development with an average annual compound growth rate of over 20% due to its technology - innovation - driven approach and rapid market response capabilities.
Listing Plan and Strategic Significance
This listing on NASDAQ marks a new stage of international development for Dexin Group. Mr. He Dexiang, the company's founder and CEO, said, "Listing on NASDAQ is an important milestone for Dexin Group. With the support of the capital market, we will further strengthen our R & D investment, optimize the global supply chain layout, and continuously enhance our brand value to create long - term returns for shareholders."
This IPO is underwritten by EarlyBirdCapital BTIG, LLC, an internationally renowned investment bank. Its rich experience in the capital market will provide strong support for Dexin Group's smooth listing on the U.S. stock market.
Future Outlook
Taking this listing as an opportunity, Dexin Group will accelerate the advancement of its new business plan. It plans to increase investment in industries such as international trade, cross - border e - commerce, and the big health industry. At the same time, it will deepen the synergy with global partners to consolidate its leading position in the industry. The company aims to achieve a double breakthrough in revenue scale and profitability through technological empowerment and market expansion within the next three years.
About Dexin Group
Dexin Group is an innovative leader in the global manufacturing and trading fields, focusing on providing efficient and reliable consumer product solutions to customers. With the core concept of "Quality - oriented, Global Win - win", the company continuously promotes industrial upgrading and globalization.
